Trends in the Prevalence of Hepatitis C Infection During Pregnancy and Maternal-Infant Outcomes in the U.S., 1998 to 2018
October 17, 2023 Can Younger Women With Hormone Receptor–Positive Breast Cancer Safely Pause Endocrine Therapy to Pursue Pregnancy? The ASCO Post
March 10, 2023 ‘Best of SABCS’: Top 7 Picks From the 2022 Meeting by Jame Abraham, MD, FACP The ASCO Post
January 25, 2023 Can Younger Women With Hormone Receptor–Positive Breast Cancer Safely Pause Endocrine Therapy to Pursue Pregnancy? The ASCO Post
June 02, 2023 Simple Hysterectomy May Be a Safe Option for Patients With Early-Stage, Low-Risk Cervical Cancer The ASCO Post
August 10, 2023 EBCTCG Meta-analysis Confirms Benefit of Ovarian Ablation or Suppression in Preventing Breast Cancer Recurrence The ASCO Post
October 17, 2023 Adjuvant Treatment With Ribociclib Reduces Risk of Recurrence in Hormone Receptor–Positive, HER2-Negative, Early-Stage Breast Cancer The ASCO Post
May 11, 2023 GOG 3026: Durable Responses With Ribociclib Plus Letrozole in Low-Grade Serous Ovarian Cancer The ASCO Post
March 29, 2023 Positive Outcomes Demonstrated in Patients With Ovarian Cancer Treated With Olaparib Prior to Surgical Intervention and Subsequent Chemotherapy The ASCO Post
March 30, 2023 Time-Related and Financial Burdens May Impact Quality of Life for Patients With Gynecologic Cancer The ASCO Post